Article Text

Download PDFPDF

Letter
‘Family-based’ strategy for Helicobacter pylori infection screening: an efficient alternative to ‘test and treat’ strategy
  1. Jiafeng Zhang1,
  2. Yuchen Deng2,
  3. Chang Liu1,
  4. Huiquan Wang1,
  5. Heifei Ren1,
  6. Sai Chen1,
  7. Lei Chen1,
  8. Bin Shi3,
  9. Lin Zhou1
  1. 1 Department of Laboratary Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China
  2. 2 Department of Dermatology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China
  3. 3 Department of Gastroenterology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China
  1. Correspondence to Prof. Lin Zhou, Department of Laboratary Medicine, Shanghai Changzheng Hospital,Naval Medical University, Shanghai, China; lynnzhou36{at}126.com; Prof. Bin Shi, Department of Gastroenterology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China; shibin7305{at}sina.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with utmost interest the study by Zhou et al,1 which was the first family-based investigation of Helicobacter pylori (Hp) infection in China. The authors provided valuable insights into the occurrence of familial cluster effect on Hp infection and the superiority of the ‘family-based strategy’. However, their work failed to compare the screening efficiency of various established Hp management methods, leaving us curious about whether the ‘family-based strategy’ could identify more Hp-infected participants with equal number of tests conducted as compared with the widely used ‘test and treat strategy’.2 Fortunately, the family-unit data in Zhou’s study offers the possibility for such exploration.

To address this gap, we built a database consisting of over one million households, based on the infection status of households and individuals from 29 provinces reported by Zhou, in order to simulate real-world scenarios. The screening protocols were simulated in national database and subdataset by province, and were defined as follows (figure 1A)1: The ‘test-and-treat strategy’ involved randomly selecting participants for Hp testing until all participants were tested.2 The ‘family-based strategy’ involved participants selecting, as well as Hp testing of family members only if the selected individual tested positive for Hp. If the selected individual tested negative, no further testing of family members was required and a new participant was selected at random; it is noteworthy that each individual was tested only once at most. The main difference between the two strategies was the order in which participants underwent Hp testing. The testing and sampling processes were simulated using Python.

Figure 1

Protocol and screening efficiency of the ‘family-based strategy’ and ‘test and treat strategy’. (A) Under the ‘test-and-treat strategy’, participants were selected at random for Hp testing until all participants had been detected. In ‘family-based strategy’, if the randomly selected individual tests positive for Hp, additional testing is carried out on all his/her family members, with the rest of the process remaining unchanged. The numbers inside the boxes represent the order of screening, and the colour indicates the Hp infection status. (B) By simulating data from Shanghai, the family-based strategy was found to identify an average of 12.15% more Hp-infected participants throughout the screening process, when same number of tests were conducted. The y-axis represents Hp-infected participants identified and x-axis indicates the number of participants screened. (C) Positive correlation of relative screening advantages of family-based strategy and real per capita GDP by province. The y-axis represents the real per capita GDP, and x-axis represents relative advantages of family-based strategy (r=0.645, p<0.01), each dot represents data from one province. GDP, gross domestic product; HP, Helicobacter pylori.

Our study found that, on average, the ‘family-based strategy’ exhibited an improvement of 4.02% in the ability to detect Hp infections throughout the screening process (table 1), despite the final number of Hp-positive individuals identified was the same after both methods were applied to all participants. We used the x-axis to represent the number of tests conducted and the y-axis to reflect the number of Hp-infected individuals tested (figure 1B). The discrepancy between the two curves in figure 1B was particularly apparent during the mid-screening period (when screening was completed for part of the population). The ‘family-based strategy’ was able to identify an additional 1.26%–12.15% of Hp-infected individuals across the 29 provinces, with the greatest advantage seen in Shanghai (12.15%) (figure 1B). Furthermore, a positive correlation was observed between the advantage of the ‘family-based strategy’ in detecting Hp infections and the per capita gross domestic product across the 29 provinces (figure 1C).

Table 1

Comparison of Helicobacter pylori screening efficiency between the two strategies

This result serves as an important complement to Zhou’s conclusion and revealed previously unknown benefits of ‘family-based management’ of Hp infection in real-world practices. Our finding suggests that searching for Hp infection along the intrafamilial transmission chain would be more effective compared with random screening, although the advantage may not be substantial. One possible explanation for the limited benefit is the ‘family-based approach’ merely connects members within the family to facilitate easier tracing of infections; however, the process of locating from one Hp-infected household to another remains randomised.

Our findings have significant implications, as the topic of comprehensive Hp screening for entire population in specific regions is currently widely discussed among gastroenterologists.3 Achieving population-wide Hp eradication often takes years or decades and, during this period, reinfection and antibiotic resistance can pose serious challenges4 5; adopting a ‘family-based approach’ would identify infected individuals more rapidly, decrease the population prevalence of Hp more quickly and break the chain of interpersonal transmission more effectively, thereby partially addressing above challenges. However, completing Hp screening across the entire population in areas with high prevalence can be challenging due to limitations in medical and financial resources; meanwhile, in areas with low prevalence, there often exist no compelling reason or motivation to complete such screening. These imply screening completed in a portion of the population is common practice for Hp testing in reality, and under this context, the advantages of ‘family-based approach’ would be well demonstrated as the current data presented. Our analysis also revealed a concordance of economic developed regions having higher benefits of implementing ‘family-based strategy’, making this strategy particularly relevant in economically developed countries with a heavy burden of gastric cancer, such as Central and Eastern Europe.

Ethics statements

Patient consent for publication

References

Footnotes

  • JZ, YD, CL and HW are joint first authors.

  • BS and LZ are joint senior authors.

  • JZ, YD, CL and HW contributed equally.

  • Contributors LZ and BS take responsibility for the integrity and accuracy of the overall content. Conception and design: LZ, BS and JZ. Drafting of manuscript: JZ, YD, CL and HW. Data collection and analysis: JZ, YD and CL. Coordination and monitoring of survey processes: HW, HR, SC and LC. Administrative, technical or material support: LZ and BS. All authors had full access to the data used to generate results in this article and have critically reviewed and approved the manuscript for publication.

  • Funding This study was supported by National Natural Science Foundation of China (82102482, 82072371), Leading Talent Project of Shanghai Huangpu District (2020-1-28), Shanghai Health and Medical Development Foundation under Grant (201972), Shanghai Science and Technology Committee under Grant (21ZR1478200).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.